Angiotensin II in septic shock: Effects on tissue perfusion, organ function, and mitochondrial respiration in a porcine model of fecal peritonitis

Critical Care Medicine

Volumn 42, Issue 8, 2014, Pages

  Corrêa, Thiago D ^a   Jeger, Victor ^a   Pereira, Adriano José ^a   Takala, Jukka ^a   Djafarzadeh, Siamak ^a   Jakob, Stephan M ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

angiotensin II; enalapril; mitochondrial respiration; multiple organ failure; norepinephrine; septic shock

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANGIOTENSIN II; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE; DOBUTAMINE; ENALAPRIL; FENTANYL; GLUCOSE; HEMOGLOBIN; HETASTARCH; INTERLEUKIN 6; LACTIC ACID; MIDAZOLAM; NORADRENALIN; OLIGOCLONAL BAND; POTASSIUM; PROPOFOL; RINGER LACTATE SOLUTION; SODIUM; TUMOR NECROSIS FACTOR ALPHA; VASOCONSTRICTOR AGENT;

4 AMINOHIPPURIC ACID CLEARANCE; ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING; BLOOD PRESSURE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; ELEVATED BLOOD PRESSURE; EXPERIMENTAL PERITONITIS; FECAL PERITONITIS; FLUID RESUSCITATION; GLUCOSE BLOOD LEVEL; HEART OUTPUT; HEART PERFUSION; HEART STROKE VOLUME; HEMODYNAMICS; HEMOGLOBIN BLOOD LEVEL; HYPOTHESIS; INFLAMMATION; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY FUNCTION TEST; KIDNEY PARENCHYMA; KIDNEY PERFUSION; KIDNEY PLASMA FLOW; LACTATE BLOOD LEVEL; LEUKOCYTE COUNT; LIVER PARENCHYMA; LIVER PERFUSION; LOW DRUG DOSE; LUNG ARTERY PRESSURE; MALE; MEAN ARTERIAL PRESSURE; MITOCHONDRIAL RESPIRATION; NONHUMAN; OUTCOME ASSESSMENT; OXYGEN CONSUMPTION; PORCINE MODEL; POTASSIUM EXCRETION; POTASSIUM URINE LEVEL; PRIORITY JOURNAL; PROMYELOCYTE; RANDOMIZED CONTROLLED TRIAL; RESUSCITATION; SEPTIC SHOCK; SKELETAL MUSCLE; SODIUM EXCRETION; SODIUM URINE LEVEL; THROMBOCYTE COUNT; TISSUE PERFUSION; TREATMENT DURATION; URINE VOLUME; ANIMAL; CELL RESPIRATION; COMPARATIVE STUDY; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; FLUID THERAPY; HYPOTENSION; MITOCHONDRION; PERITONITIS; PHYSIOLOGY; PIG; RANDOMIZATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SHOCK, SEPTIC;

ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; CARDIAC OUTPUT; CELL RESPIRATION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUID THERAPY; HEMODYNAMICS; HYPOTENSION; MALE; MITOCHONDRIA; NOREPINEPHRINE; PERITONITIS; RANDOM ALLOCATION; RENIN-ANGIOTENSIN SYSTEM; SHOCK, SEPTIC; SWINE; VASOCONSTRICTOR AGENTS;

EID: 84904755293     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000000397     Document Type: Article

References (35)

1. De Backer D, Aldecoa C, Njimi H, et al: Dopamine versus norepinephrine in the treatment of septic shock: A meta-analysis. Crit Care Med 2012; 40:725-730
2. Dellinger RP, Levy MM, Rhodes A, et al; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup: Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41:580-637
3. Dünser MW, Ruokonen E, Pettilä V, et al: Association of arterial blood pressure and vasopressor load with septic shock mortality: A post hoc analysis of a multicenter trial. Crit Care 2009; 13:R181
4. Schmittinger CA, Dünser MW, Torgersen C, et al: Histologic pathologies of the myocardium in septic shock: A prospective observational study. Shock 2013; 39:329-335
5. Russell JA, Walley KR, Singer J, et al; VASST Investigators: Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008; 358:877-887
6. Thomas VL, Nielsen MS: Administration of angiotensin II in refractory septic shock. Crit Care Med 1991; 19:1084-1086
7. Wray GM, Coakley JH: Severe septic shock unresponsive to noradrenaline. Lancet 1995; 346:1604
8. Yunge M, Petros A: Angiotensin for septic shock unresponsive to noradrenaline. Arch Dis Child 2000; 82:388-389
9. Wan L, Langenberg C, Bellomo R, et al: Angiotensin II in experimental hyperdynamic sepsis. Crit Care 2009; 13:R190
10. May CN, Ishikawa K, Wan L, et al: Renal bioenergetics during early gram-negative mammalian sepsis and angiotensin II infusion. Intensive Care Med 2012; 38:886-893
11. Corrêa TD, Vuda M, Takala J, et al: Increasing mean arterial blood pressure in sepsis: Effects on fuid balance, vasopressor load and renal function. Crit Care 2013; 17:R21
12. Corrêa TD, Vuda M, Blaser AR, et al: Effect of treatment delay on disease severity and need for resuscitation in porcine fecal peritonitis. Crit Care Med 2012; 40:2841-2849
13. Mehta RL, Kellum JA, Shah SV, et al; Acute Kidney Injury Network: Acute Kidney Injury Network: Report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11:R31
14. Regueira T, Bänziger B, Djafarzadeh S, et al: Norepinephrine to increase blood pressure in endotoxaemic pigs is associated with improved hepatic mitochondrial respiration. Crit Care 2008; 12:R88
15. Vuda M, Brander L, Schröder R, et al: Effects of catecholamines on hepatic and skeletal muscle mitochondrial respiration after prolonged exposure to faecal peritonitis in pigs. Innate Immun 2012; 18:217-230
16. Motwani JG, Struthers AD: Dose-response study of the redistribution of intravascular volume by angiotensin II in man. Clin Sci (Lond) 1992; 82:397-405
17. Doerschug KC, Delsing AS, Schmidt GA, et al: Renin-angiotensin system activation correlates with microvascular dysfunction in a prospective cohort study of clinical sepsis. Crit Care 2010; 14:R24
18. Bucher M, Ittner KP, Hobbhahn J, et al: Downregulation of angiotensin II type 1 receptors during sepsis. Hypertension 2001; 38:177-182
19. Schmidt C, Höcherl K, Kurt B, et al: Blockade of multiple but not single cytokines abrogates downregulation of angiotensin II type-I receptors and anticipates septic shock. Cytokine 2010; 49:30-38
20. Schrier RW, Wang W: Acute renal failure and sepsis. N Engl J Med 2004; 351:159-169
21. Langenberg C, Wan L, Egi M, et al: Renal blood fow in experimental septic acute renal failure. Kidney Int 2006; 69:1996-2002
22. Mortensen EM, Restrepo MI, Anzueto A, et al: The impact of prior outpatient ACE inhibitor use on 30-day mortality for patients hospitalized with community-acquired pneumonia. BMC Pulm Med 2005; 5:12
23. Schmidt H, Hoyer D, Rauchhaus M, et al: ACE-inhibitor therapy and survival among patients with multiorgan dysfunction syndrome (MODS) of cardiac and non-cardiac origin. Int J Cardiol 2010; 140:296-303
24. Hagiwara S, Iwasaka H, Matumoto S, et al: Effects of an angiotensin-converting enzyme inhibitor on the infammatory response in in vivo and in vitro models. Crit Care Med 2009; 37:626-633
25. Ferrario CM, Strawn WB: Role of the renin-angiotensin-aldosterone system and proinfammatory mediators in cardiovascular disease. Am J Cardiol 2006; 98:121-128
26. Routledge HC, Chowdhary S, Townend JN: Heart rate variability-A therapeutic target? J Clin Pharm Ther 2002; 27: 85-92
27. de Cavanagh EM, Piotrkowski B, Basso N, et al: Enalapril and losar-tan attenuate mitochondrial dysfunction in aged rats. FASEB J 2003; 17:1096-1098
28. Merlin ME, Campello AP, Klüppel ML: Enalapril maleate affects 2-oxo-glutarate metabolism in mitochondria from the rat kidney cortex. Cell Biochem Funct 1994; 12:21-28
29. Wang XM, Yang L, Chen KM: Catecholamines: Important factors in the increase of oxidative phosphorylation coupling in rat-liver mitochondria during the early phase of burn injury. Burns 1993; 19:110-112
30. Kiil F, Aukland K, Refsum HE: Renal sodium transport and oxygen consumption. Am J Physiol 1961; 201:511-516
31. Redfors B, Bragadottir G, Sellgren J, et al: Acute renal failure is NOT an "acute renal success"-A clinical study on the renal oxygen supply/demand relationship in acute kidney injury. Crit Care Med 2010; 38:1695-1701
32. Theken KN, Deng Y, Schuck RN, et al: Enalapril reverses high-fat diet-induced alterations in cytochrome P450-mediated eicosanoid metabolism. Am J Physiol Endocrinol Metab 2012; 302:E500-E509
33. Leininger MT, Portocarrero CP, Schinckel AP, et al: Physiological response to acute endotoxemia in swine: Effect of genotype on energy metabolites and leptin. Domest Anim Endocrinol 2000; 18:71-82
34. Barth E, Albuszies G, Baumgart K, et al: Glucose metabolism and catecholamines. Crit Care Med 2007; 35:S508-S518
35. Träger K, Radermacher P, Rieger KM, et al: Norepinephrine and nomega-monomethyl-L-arginine in porcine septic shock: Effects on hepatic O2 exchange and energy balance. Am J Respir Crit Care Med 1999; 159:1758-1765